Background: Several utility-based instruments have been applied in cost-utility analysis to assess health state values for people with dementia. Nevertheless, concerns and uncertainty regarding their performance for people with dementia have been raised. Objectives: To assess the performance of available utility-based instruments for people with dementia by comparing their psychometric properties and to explore factors that cause variations in the reported health state values generated from those instruments by conducting metaregression analyses. Methods: A literature search was conducted and psychometric properties were synthesized to demonstrate the overall performance of each instrument. When available, health state values and variables such as the type of instrument and cognitive impairment levels were extracted from each article. A meta-regression analysis was undertaken and available covariates were included in the models. Results: A total of 64 studies providing preference-based values were identified and included. The EuroQol five-dimension questionnaire demonstrated the best combination of feasibility, reliability, and validity. Meta-regression analyses suggested that significant differences exist between instruments, type of respondents, and mode of administration and the variations in estimated utility values had influences on incremental quality-adjusted life-year calculation. Conclusions: This review finds that the EuroQol fivedimension questionnaire is the most valid utility-based instrument for people with dementia, but should be replaced by others under certain circumstances. Although no utility estimates were reported in the article, the meta-regression analyses that examined variations in utility estimates produced by different instruments impact on costutility analysis, potentially altering the decision-making process in some circumstances.
Introduction
Dementia has become one of the leading chronic disease contributors to disability and dependency among the elderly worldwide. The total number of people living with dementia was estimated globally to be 47.5 million in 2015 and has been predicted to reach 75.63 million in 2030 and 135.46 million in 2050 [1] . The estimated worldwide cost of dementia in 2010 was approximately $604 billion, and has been conservatively predicted to increase by 85% by 2030 [1] .
As the global population ages and the prevalence of dementia increases, the proportion of constrained health care resources required for dementia care is also likely to increase. Health care reimbursement authorities around the world have recommended the use of cost-utility analysis (CUA) to determine the costeffectiveness of new health care interventions. Converting the effectiveness data to cost per quality-adjusted life-year (QALY) gain enables the CUA to simultaneously integrate the changes in both quantity (length) of life (mortality) and quality of life (morbidity) [2] . The QALY weights can be obtained directly using elicitation methods or indirectly using questionnaire-type multiattribute utility instruments.
A number of multi-attribute utility instruments such as the EuroQol five-dimension questionnaire (EQ-5D) [3] [4] [5] and recently developed dementia-specific utility-based instruments such as the DEMQOL-U [6, 7] have been applied in CUA to assess preference weights for people with dementia. Nevertheless, significant variations were observed in the literature and concerns have been raised regarding the performance of those instruments [8, 9] . For instance, generic instruments such as the EQ-5D are widely used because they facilitate comparisons across disparate diseases and interventions in standard economic evaluations. Nevertheless, the classification systems of generic instruments may lack sensitivity to important differences in health status for specific conditions and diseases, such as dementia. Consequently, dementia-specific instruments may be more attractive to both researchers and funding authorities. Furthermore, assessing utility values is a complex and challenging issue for people with dementia, who suffer from constraints in judgment, thinking processes, and communicative abilities, resulting in high rates of nonresponders. In this case, it is likely that neither generic nor disease-specific utility-based instruments are able to capture every aspect of quality of life for people with dementia.
People with dementia also consistently have higher self-reported utility scores than those reported by a proxy [10] [11] [12] . Considering the loss of insight that has been found to be common in dementia, the higher ratings of patients may reflect a lack of insight into their impairments. Hence, proxy ratings may be more reliable and accurate for people with dementia and, thus, may be more reliable in CUA for policy decisions. On the contrary, studies have shown that caregivers may emphasize the negative aspects and overlook all positive aspects of a patient's quality of life, resulting in relatively low utility ratings, whereas the meaningful information that can be transmitted by people with dementia is overlooked, rather than interpreted by others [13] . No consensus has been reached in the literature as to whether the patient-reported or proxy-reported scores are more appropriate to be used in QALY calculation.
Furthermore, research has shown that differences exist within utility values obtained using various preference-based instruments from the same samples. For example, reported mean utility scores were the highest for the EQ-5D, followed by the Quality of Well-Being (QWB) and the Health Utilities Index (HUI), in studies in which these three instruments were administered to the same patients [12, 14] . Studies suggested that both preference measurement technique to weight instrument items (time trade-off vs. standard gamble) and the utility combination rule (additive, multiplicative, and regression) may internally lead to differences across different utility-based instruments [15, 16] . Nevertheless, wide variations in reported utility values were also found for the same instrument across different samples. For instance, the reported HUI scores for people with moderate dementia varied between 0.53 and 0.87 [14, 17] . Such differences may indicate that not only the instrument itself but also the study-level covariates such as patients' characteristics and methodology could have impacts on reported utility values.
The need for greater understanding of utility weights for people with dementia has been highlighted in the most recent literature [18, 19] . It is particularly important to ensure that the values of the measured health states obtained from utility-based instruments are reliable and robust and enable accurate and consistent calculation of QALYs for economic evaluations. To our knowledge, one study has reviewed preference weights for people with dementia obtained from the EQ-5D between 1990 and 2009 [9] . Another study reviewed all relevant utility-based instruments, but only for people with Alzheimer disease (AD) and on the basis of data collected during the period from 2000 to 2011 [8] . Consequently, this study aimed to fill the literature gap by 1) providing a comprehensive comparison of performance (feasibility, precision, reliability, validity, and responsiveness) of all utility-based instruments for people with dementia through a systematic review of published evidence and 2) investigating the factors contributing to the variations in utility values obtained from different utilitybased instruments through meta-regression analyses.
Methods

Literature Search and Inclusion Criteria
This systematic review was conducted in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines [20] . A database search was performed in April 2016. The search included the electronic databases of EuroQol, MED-LINE, CINAHL, Cochrane Library, Embase, PsycINFO, Econlit, and PubMed, using the search terms listed in Appendix Table A1 in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval. 2017.09.005. Additional articles were found through citations and an updated database search in January 2017. The study selection process was performed by two independent reviewers who initially screened the titles and abstracts for eligibility. The fulltext versions of all included studies were then obtained and reviewed for eligibility using the same inclusion and exclusion criteria. Differences between the results of the two reviewers were resolved by discussion with a third reviewer.
Articles were included in this review if they 1) were published in English; 2) involved any type and stage of dementia, including AD, vascular dementia, or dementia with Lewy bodies; and 3) were studies in which health state values or preference weights were presented as outcome measures. Working papers, protocols, editorials or letters, systematic reviews, abstracts, and studies that lacked reported health state values were excluded.
Systematic Review and Analysis of Utility-Based Instrument Performance
From the studies that satisfied the inclusion criteria, information or data relevant to the instruments' psychometric properties were extracted to investigate their performance for people with dementia. An instrument's measurement performance can be assessed by its feasibility, precision, reliability, validity, and responsiveness. Feasibility represents the willingness or ability of participants to complete an instrument [21] . Although difficult to evaluate directly, this is most readily assessed through time taken to complete the instrument, response rates, and number of missing items [9] . Precision is the ability of an instrument to distinguish changes in relation to the reported health states [21] . When more than 20% of respondents have maximum good or bad health scores, this indicates ceiling or floor effects, respectively [21] . Reliability is defined as the ability to provide stable instrument scores when repeated on an unchanged population, which can be assessed by measuring the test-retest correlation over two points in time [22] . In addition, reliability in instruments refers to the comparability of responses across different assessors (such as patient and proxy report), which can be measured by the interrater agreement [23] . Instruments are considered to be strongly reliable and recommended if correlation coefficient estimates are greater than 0.70 [21, 24] . Validity is the ability of the dimensions of an instrument to adequately cover the core determinants of health-related utility. Applied to health state preferences, content validity refers to the adequacy of the health state description (classification system) in representing health status [25] . Construct validity is assessed by either convergence validity (correlation between targeted instrument and other quality-of-life measures) or known-group validity (correlation of utility values obtained from groups that are expected to differ in cognitive impairment levels) [21, 23] . The strength of correlation is considered to be weak if estimates are less than 0.3, moderate if less than 0.5, and strong if more than 0.50 [23] . Responsiveness is defined as the ability of an instrument to measure changes in health-related utility over time [21] . It is difficult to assess responsiveness because no criterion standard is available for comparison. Nevertheless, effect size can be viewed as the most common indicator for assessing responsiveness for instruments. Instruments are considered to be the most responsive if the effect size score is more than 0.80, moderately responsive if the score is between 0.5 and 0.8, and mildly responsive if the score is only larger than 0.2 [21] .
Meta-Regression Analysis of the Utility Values
Examining how the properties of different instruments influence the utility values derived for people with dementia (the study's second aim) will help us understand the potential impacts of using a particular instrument in calculating the most important outcome measure in the CUA-the QALY. To this end, we conducted a meta-regression analysis. This approach has the advantage of combining all published data on utility values and potentially yields more accurate utility estimates for mild, moderate, and severe levels of dementia, as well as providing insight into the factors that influence health state values.
In our meta-regression analyses, the dependent variable was "mean utility values" and the explanatory variables included utility-based instruments, cognitive impairment levels, mean age, and other relevant variables, which were all extracted from studies included in the systematic review. The "respondents" variable was included as one of the controlled variables because patient self-reporting scores have been consistently reported in the literature to be higher than proxy-reporting scores [26] . The "administrations" variable was chosen because the preferencebased weights might be more precise if collected via face-to-face interview, compared with a survey or phone interview method [27] . Mean age, sample size, disease types, and severity levels were taken into consideration in the regression because they were believed to correlate with different health state values [26, 28] . Last, the year of publication was considered in this study to explore the possibility of improved methodology (both surveys and statistical analysis) in recent years [29] .
The base model (model 1), estimated by the least squares method with robust standard error, is specified as follows:
Findings in the literature indicated that using utility weights derived from populations other than that being studied (for instance, a European utility weight on an American population) could bias the utilities measured and adversely affect the results of economic evaluations [30] . The results from a recent investigation by Fang et al. [31] , however, indicated that no important differences were found in obtaining utility values by using other countries' population utility weights. Hence, value sets for each instrument and study regions for individual studies were added in model 2 to investigate whether differences between the population of interest and the population from which the utility weight was derived will contribute to the variations in measured health state values.
In many studies, patients' cognitive impairment levels were not measured as a continuous variable but by categories (e.g., mild, moderate, and severe). To explore the impact on utility values of using different measures for patients' cognitive impairment levels, the continuous variable of severity levels in model 1 was replaced by categorical severity levels variable in model 3. Similarly, the severity levels variable was replaced by the categorical severity levels variable to form model 4 in our analyses.
The number of studies per outcome of interest required for the regression analysis to be plausible in the multivariate setting is about 40 and an absolute minimum of 10 depending on the level of heterogeneity across studies [32] . According to this guideline, the meta-regression analyses include only variables with observations from at least 10 different studies. All statistical analyses were performed using STATA 14.1 (StataCorp LP, College Station, TX).
Results
The database search identified 64 articles including 3 identified from the reference lists and citations of retrieved articles (Fig. 1) . Six utility-based instruments ( 
Evaluation of the Utility-Based Instruments' Performance
Feasibility
Completion time, response rate, and missing items of each instrument are presented as the average values across studies in Table 2 . Overall, the EQ-5D demonstrated the best feasibility among six utility-based instruments, with the lowest completion time and missing items but higher completion rate for both patient self-reporting and proxy-reporting [14, 33] . The completion rates were 100% for the caregivers using the HUI2 as well as patients with mild AD using the HUI3 [13, 16] . Missing items were only 2.8% for the caregiver version of the DEMQOL-U [6] .
Precision
The systematic review indicated that a ceiling effect on the EQ-5D was reported across various studies [6, 12, 14, 31, 34] . No ceiling effect was found for the HUI, but the authors suggested a potential floor effect [14] . A ceiling effect was found for the DEMQOL-U and both ceiling and floor effects were discovered for the DEMQOL-Proxy-U. Other instruments such as the QWB and the Assessment of Quality of Life (AQoL) reported no ceiling or floor effects, and so were considered to have better precision compared with instruments with significant ceiling or floor effects.
Reliability
The EQ-5D [14, 33, [35] [36] [37] , HUI3 [13] , and QWB [14] were reported to have moderate to strong test-retest reliability compared with the 15D, AQoL, and DEMQOL-U. This finding indicates that stable utility values can be achieved using those three instruments on an unchanged population, particularly for patients with mild cognitive impairment. Nevertheless, the inter-rater agreement, which represents the association between patient-and proxyreported values, was found to have a moderate level for all utility-based instruments.
Validity
First, the content validity was assessed for three instruments and it was concluded that there was a mismatch of reported content between patients' and caregivers' reports of what was critical to their quality of life and the content of the three instruments. The QWB included the largest number of items that were identified by patients and caregivers as important in assessing their quality of life compared with the HUI and the EQ-5D [38] . Studies showed moderate to strong convergence validity for the EQ-5D [39] [40] [41] [42] [43] , the AQoL [44] , and the QWB [12, 14] . The findings for the HUI were not consistent across studies. For example, no convergence validity for the HUI was reported in three studies, whereas a moderate convergence validity was reported in two other studies [14, 35, 37, 45] . Most of the articles reported significant moderate to strong known-group validity of the EQ-5D [6, [46] [47] [48] [49] . Again, conflicting evidence was found across studies for the known-group validity of the HUI. For instance, no known-group validity was
reported in the study by Neumann et al. [17] but a strong (40.7) validity was reported for the HUI in other studies [45, 50] .
Responsiveness
Only the EQ-5D has been reported as having an effect size higher than 0.5, indicating at least medium responsiveness of the EQ-5D compared with other instruments.
Meta-Regression Analyses Results
The studies and observations selected for the meta-regression analyses are outlined in Figure 2 . In total, 46 studies were included in the analysis. The most commonly applied utilitybased instrument was the EQ-5D, followed by the HUI2/3. Most of the EQ-5D values were based on a UK value set (n ¼ 35), whereas the Danish value set was least presented (n ¼ 4). Definitions, summary statistics, and expected impact on the mean utility values of those extracted variables are presented in Table 3 .
Results of the meta-regression analyses are presented in Table 4 . Overall, the instruments, respondents, and severity levels variables were found to increase mean utility values across four different models (positive coefficients). The categorical severity levels variable expectedly declined utility values (negative coefficients). The coefficients of the administrations variable were positive and significant in models 3 and 4 but not in models 1 and 2, whereas the coefficients of mean age were positive and significant in models 1 and 2 but not in models 3 and 4. Disease types, sample size, and year of publication (both continuous and categorical) had no impact on mean utility value estimation across models. The direction of impacts confirmed our expectations specified in Table 3 , except for the coefficient for mean age.
As can be seen from Table 4 , our meta-regression analyses results indicate that the self-reported health state values for patients with dementia are generally around 0.14 points higher than values reported by their caregivers. Patients with severe dementia predictably rate their utility values approximately 0.12 points lower compared with people with moderate dementia and double the magnitude compared with people with mild dementia. Most importantly, utility-based instruments were found to be a statistically significant predictor of mean health state values. The estimated utility values obtained from the EQ-5D are higher than those obtained from the HUI. More specifically, it was 0.13 points higher than in model 1 and 0.17 points than in model 3.
To illustrate the impact that variability in utility estimates would have on the CUA, we created hypothetical scenarios that 
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Number of health states generated from the DEMQOL-U and the DEMQOL-U-Proxy, respectively. †
The three-level EQ-5D included a three-level scale in the health state descriptive system of "having no problems," "having some or moderate problems," "being unable to do/having extreme problems." The five-level EQ-5D included a five-level scale of "having no problems," "having slight problems," "having moderate problems," "having severe problems," and "being unable to do/ having extreme problems." ‡ The EQ-5D contained various value sets (previously known as "tariffs"), representing valuations that have been elicited for all possible health states defined by the EQ-5D descriptive system.
Currently, 16 country-specific value sets are available for the three-level EQ-5D and six for the five-level EQ-5D. Valuation studies for the five-level EQ-5D are still under development in a number of countries. In most countries, value sets are elicited by either the VAS or the TTO. § Number of health states generated from the three-level and the five-level EQ-5D, respectively.
compared a new intervention (drug B) with an existing best alternative (drug A) (see Appendix Table A3 in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.2017.09.005). Drug B was assumed to effectively delay the dementia progression from mild to moderate from 2 years to 5 years. We then compared the changes in incremental QALYs resulting from differences in the magnitude of utility estimates in different scenarios. First, the predicted incremental QALYs were 3.012 and 2.622 for the EQ-5D and HUI, respectively, after adjusting other factors. Second, the predicted incremental QALYs were 3.432 and 3.012 for the patient self-and proxy-reported EQ-5D scores, respectively, after controlling for other factors. Third, the predicted incremental QALYs were 2.76 and 1.71 for using the EQ-5D administered by face-to-face interview and other methods (such as phone interview), respectively, after holding other factors constant. On the basis of the aforementioned calculations, the incremental cost-effectiveness ratio (ICER), which is expressed as the ratio of incremental costs (cost of drug B minus cost of drug A) over incremental QALY (QALY of drug B minus QALY of drug A), is expected to be the highest in the CUA when using the EQ-5D self-completed scores through face-to-face interview and the lowest when using the HUI proxy-rated scores via other administration modes (see Appendix Figure A1 ⁎ Ceiling or floor effects were indicated when 20% of respondents achieved maximum good or bad health scores, respectively. † Reliability was considered to be weak when the correlation coefficient was o0.4, moderate when between 0.4 and 0.7, and strong when 40.7. ‡ There were 56 attributes identified from both patients and caregivers that were important in measuring the quality of life. § Validity was considered to be moderate when the coefficient was between 0.3 and 0.5 and strong when larger than 0.5. || Instruments were considered to be the most responsive if the effect size score was more than 0.80 and moderately responsive if the score was more than 0.5. 2 0 1 8 ) 4 7 
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Discussion
In this study, we conducted a literature review to compare the performance of utility-based instruments for people with dementia and a meta-regression analysis to explore factors that contributed to the variation in utility values derived from different instruments. This is the first and most comprehensive systematic review that examines the psychometric properties of available utility-based instruments for people with dementia (including AD). The meta-regression analyses quantified the variation between preference weights obtained from different utility-based instruments.
The EQ-5D demonstrated better feasibility, reliability, and validity than did other utility-based instruments in the review, but the usefulness for people with dementia may be restricted by its ceiling effect. The review showed that the EQ-5D was the most commonly used utility-based instrument for researchers to derive preference weights for people with dementia. This may be due to its relatively simple three-level scale descriptive system compared with other instruments such as the HUI. Nevertheless, the relatively simple descriptive system may contribute to its ceiling effect. The meta-regression analyses results showed that the EQ-5D produces higher estimated utility values than do other instruments, which is a reflection of its ceiling effect. A new version of the EQ-5D with a five-level scale was developed to overcome the ceiling effect limitations. This five-level EQ-5D has been validated in reducing the ceiling effect while improving discriminatory power and establishing convergence and knowngroup validity [51] . Nevertheless, no similar investigation has been conducted for patients with dementia and, therefore, its performance for people with dementia remains unclear.
The HUI and QWB may perform better than the EQ-5D in terms of content validity and precision. The QWB covered a large number of attributes that people with dementia and their caregivers identified to be important in measuring their quality of life. For instance, the QWB addresses all attributes of physical wellbeing considered important by both people with dementia and caregivers. The EQ-5D asks only for the level of pain/discomfort that the individual is experiencing rather than directly addressing the attributes of physical illnesses, ailments, and frailty [38] . In addition, both the QWB and the HUI perform well for people with mild cognitive impairment with no ceiling or floor effect evidence, and the completion rate for the HUI was reported as 100% in the literature [14] . This finding indicates that the selection of the appropriate utility-based instrument for people Instruments and value sets cannot appear in the same regression models because of perfect collinearity.
with dementia should consider not only the simplicity but also other aspects such as the objectives of the study, target population, and their level of cognitive impairment.
The performance of the AQoL and the 15D in measuring health states for people with dementia is uncertain because of insufficient information available in the literature. For example, only two studies for the AQoL and three studies for the 15D were included in our review and meta-regression analyses. In addition, their psychometric properties were not fully assessed to be compared with other instruments. The DEMQOL-U, the only dementia-specific preference-weight measure included in this study, did not show better psychometric properties than the EQ-5D, QWB, and HUI. This result, however, may be constrained by the availability and inclusion of only two relevant studies. Hence, further investigation regarding the validity of the DEMQOL-U for people with dementia is needed.
Several results from the meta-regression analyses were in agreement with discussion on the variations in utility values in 
literature. The findings may have important implications for researchers when choosing a suitable instrument for people with dementia so as to achieve reliable QALYs and ICERs in economic evaluation. For instance, the significant differences between selfand proxy-reported scores may suggest that a utility-based instrument with both self-and proxy-completed versions may be necessary because people with dementia and their caregivers have different opinions in assessing various aspects of their quality of life. Failing to prove that the face-to-face interview is a superior administration method may suggest that other costeffective administration methods, such as an online panel or computer-assisted interview techniques, may be considered valid in future studies [26, 52] . In addition, our findings were in agreement with Fang et al. [31] and may indicate that different value sets and adjustments may not be necessary when using instruments to calculate health utility scores for people with dementia. Notably, contradiction was indicated for the mean age and type of disease across models. This finding may be clinically important, and further investigations of a larger population are therefore needed to provide an explanation for our findings. Most importantly, we used hypothetical scenarios to demonstrate the impact that differences in estimated utility values have on the QALY and ICER calculations, and the findings may provide useful information for decision makers to better understand CUA outcomes. Our results indicated that using the EQ-5D as the utility-based instrument for people with dementia yields a higher incremental QALY and hence lower ICER. In addition, different respondents (people with dementia or caregivers) and modes of administration (face-to-face interview or others) will also result in different ICERs using the same instrument. The proposed health intervention will not be considered as cost-effective by the policymakers if the ICER is lower than the decision threshold level (such as $25,000/QALY gain). In other words, the decisionmaking process may be biased if QALYs are calculated from the proxy-rated HUI scores via phone interview for people with dementia because those factors will generate lower QALYs and hence higher ICERs in CUAs.
As with all systematic reviews and meta-regression analyses, this study was limited by the quality and quantity of the available publications. First, a considerable number of health state values were included in this study even though a limited number of published studies with health state values were identified. Furthermore, most of the data were collected and extracted from studies using the EQ-5D as the utility-based instrument, which may have resulted in measurement errors and bias. Our analyses were unable to specifically compare the values derived from the EQ-5D or the HUI with other available instruments such as the 15D, AQoL, QWB, DEMQOL-U, and DEMQOL-Proxy-U because of insufficient sample sizes. In addition, no investigation of possible publication bias was conducted, which may have affected the reliability of the analyses and represents a potential problem with this study.
A linear regression model with robust standard error estimates was applied for the meta-regression analyses. The overall fit was considered as good, with more than half the variance (R 2 ¼ 0.50) explained by the association between the observed and fitted health state values across all regression models. Nevertheless, it placed no restrictions on the predicted values that normally range from 0 to 1. Moreover, the contradictory results for the effect of mean age on mean utility scores suggested that 
Conclusions
The literature review concluded that the EQ-5D remains the most useful utility-based instrument for people with dementia. It should, however, be noted that this conclusion is based on a literature review in which most of the included studies used the EQ-5D to derive health state values for people with dementia. Meanwhile, other instruments demonstrated equivalent performance, or even better, in specific cases. The meta-regression analyses results and hypothetical scenarios showed that variations in estimated utility values can result in higher or lower QALY calculation and hence lead to different decision-making processes for health interventions. These findings can be viewed as a warning for researchers to choose the most reliable utilitybased instruments to provide reliable QALY and ICER measures in health economic evaluations for policymakers. Assessing quality of life is a complex and challenging issue for people with dementia, who experience constraints in judgment, thinking processes, and communicative abilities. This study revealed that currently available utility-based instruments may not perform well for people with dementia. Future studies could develop a disease-specific utility-based instrument for dementia that is able to capture every aspect of quality of life for people with dementia and display better measurement properties.
